Big Data for Public Health Policy-Making: Policy Empowerment

2017 ◽  
Vol 20 (6) ◽  
pp. 312-320 ◽  
Author(s):  
Laura Mählmann ◽  
Matthias Reumann ◽  
Nikolaos Evangelatos ◽  
Angela Brand
Keyword(s):  
Public Health ◽  
Big Data ◽  
Health Policy ◽  
Public Health Policy ◽  
Policy Making

scholarly journals Clinical validation of a public health policy-making platform for hearing loss (EVOTION): protocol for a big data study

BMJ Open ◽  
2018 ◽  
Vol 8 (2) ◽  
pp. e020978 ◽  
Author(s):  
Giorgos Dritsakis ◽  
Dimitris Kikidis ◽  
Nina Koloutsou ◽  
Louisa Murdin ◽  
Athanasios Bibas ◽  
...  
Keyword(s):  
Public Health ◽  
Hearing Loss ◽  
Big Data ◽  
Health Policy ◽  
Data Collection ◽  
Public Health Policy ◽  
Policy Making ◽  
Ethics Committee ◽  
Prospective Data ◽  
The Uk

IntroductionThe holistic management of hearing loss (HL) requires an understanding of factors that predict hearing aid (HA) use and benefit beyond the acoustics of listening environments. Although several predictors have been identified, no study has explored the role of audiological, cognitive, behavioural and physiological data nor has any study collected real-time HA data. This study will collect ‘big data’, including retrospective HA logging data, prospective clinical data and real-time data via smart HAs, a mobile application and biosensors. The main objective is to enable the validation of the EVOTION platform as a public health policy-making tool for HL.Methods and analysisThis will be a big data international multicentre study consisting of retrospective and prospective data collection. Existing data from approximately 35 000 HA users will be extracted from clinical repositories in the UK and Denmark. For the prospective data collection, 1260 HA candidates will be recruited across four clinics in the UK and Greece. Participants will complete a battery of audiological and other assessments (measures of patient-reported HA benefit, mood, cognition, quality of life). Patients will be offered smart HAs and a mobile phone application and a subset will also be given wearable biosensors, to enable the collection of dynamic real-life HA usage data. Big data analytics will be used to detect correlations between contextualised HA usage and effectiveness, and different factors and comorbidities affecting HL, with a view to informing public health decision-making.Ethics and disseminationEthical approval was received from the London South East Research Ethics Committee (17/LO/0789), the Hippokrateion Hospital Ethics Committee (1847) and the Athens Medical Center’s Ethics Committee (KM140670). Results will be disseminated through national and international events in Greece and the UK, scientific journals, newsletters, magazines and social media. Target audiences include HA users, clinicians, policy-makers and the general public.Trial registration numberNCT03316287; Pre-results.

A Modelling Framework for Evidence-based Public Health Policy Making

2022 ◽  
pp. 1-1
Author(s):  
Marios Prasinos ◽  
Ioannis Basdekis ◽  
Marco Anisetti ◽  
George Spanoudakis ◽  
Dimitris D.G Koutsouris ◽  
...  
Keyword(s):  
Public Health ◽  
Health Policy ◽  
Public Health Policy ◽  
Policy Making ◽  
Evidence Based ◽  
Modelling Framework

Evidence Based Public Health Policy Making: Tool Support

2019 ◽  
Author(s):  
Ioannis Basdekis ◽  
Konstantin Pozdniakov ◽  
Marios Prasinos ◽  
Konstantina Koloutsou
Keyword(s):  
Public Health ◽  
Health Policy ◽  
Public Health Policy ◽  
Policy Making ◽  
Tool Support ◽  
Evidence Based

NATIONAL GUIDELINES FOR HIGH-COST DRUGS IN BRAZIL: ACHIEVEMENTS AND CONSTRAINTS OF AN INNOVATIVE NATIONAL EVIDENCE-BASED PUBLIC HEALTH POLICY

2013 ◽  
Vol 29 (2) ◽  
pp. 198-206 ◽  
Author(s):  
Paulo D. Picon ◽  
Alberto Beltrame ◽  
David Banta
Keyword(s):  
Public Health ◽  
Health Policy ◽  
Healthcare System ◽  
Public Health Policy ◽  
Policy Making ◽  
Social Inequalities ◽  
Critical Issue ◽  
Public Healthcare ◽  
Evidence Based ◽  
National Guidelines

Introduction: The translation of best evidence into practice has become an important purpose of policy making in health care. In Brazil, a country of continental dimensions with widespread regional and social inequalities, the dissemination and use of the best-evidence in policy making is a critical issue for the healthcare system.Objectives: The main purpose of this study is to describe an evidence-based public health policy with special emphasis on guidelines creation for high-cost medicines. We also describe how that strategy was diffused to the judiciary system and to other parts of the healthcare system.Results: We present an 11-year follow-up of a national project for creating and updating guidelines for high-cost medicines in Brazil. A total of 109 national guidelines were published (new or updated versions) for 66 selected diseases, the first such effort in Brazilian history. The project influenced the Brazilian legislature, which has recently established a Federal Law requiring national guidelines for any new technology listed for payment by the Brazilian public healthcare system.Conclusion: We were able to involve many different stakeholders in a partnership between academia and policy makers, which made possible the widespread dissemination of the clinical practice guidelines. Problems and constraints were also encountered. This evolving public health strategy might be useful for other developing countries.

Sign in / Sign up

Export Citation Format

Share Document